At baseline, both groups were comparable regarding age (p=0.951), sex (p=0.417), BMI (p=0.939), duration of diabetes mellitus (DM) (p=0.111), interventions (including insulin, and/or oral hypoglycemic agents (OHA), p=0.985), injury mechanism (p=0.811), hypertension (p=1.000), history of alcohol intake (p=0.774), and history of tobacco intake (p=0.876) (Tables 1-2). In HBOT and SWC groups, most of the patients had controlled diabetes (83.33% and 80%, respectively), and were on OHA and/or insulin. The gene discussed is INS; the disease is diabetes mellitus.